Pharmaceutical engineering

Last updated

Pharmaceutical engineering is a branch of engineering focused on discovering, formulating, and manufacturing medication, analytical and quality control processes, and on designing, building, and improving manufacturing sites that produce drugs. It utilizes the fields of chemical engineering, biomedical engineering, pharmaceutical sciences, and industrial engineering. [1]

Contents

History

Humans have a long history of using derivatives of natural resources, such as plants, as medication. However, it was not until the late 19th century when the technological advancements of chemical companies were combined with medical research that scientists began to manipulate and engineer new medications, drug delivery techniques, and methods of mass production. [2]

Synthesizing new medications

One of the first prominent examples of an engineered, synthetic medication was made by Paul Erlich. Erlich had found that Atoxyl, an arsenic-containing compound which is harmful to humans, was very effective at killing Treponema pallidum , the bacteria which causes syphilis. He hypothesized that if the structure of Atoxyl was altered, a "magic bullet" could potentially be identified which would kill the parasitic bacteria without having any adverse effects on human health. [3] He developed many compounds stemming from the chemical structure of Atoxyl and eventually identified one compound which was the most effective against syphilis while being the least harmful to humans, which became known as Salvarsan. Salvarsan was widely used to treat syphilis within years of its discovery. [4]

Beginning of mass production

Equipment for deep-fermentation of penicillin Equipment used for making early forms of penicillin. Wellcome L0015393.jpg
Equipment for deep-fermentation of penicillin

In 1928, Alexander Fleming discovered a mold named Penicillium chrysogenum which prevented many types of bacteria from growing. Scientists identified the potential of this mold to provide treatment in humans against bacteria which cause infections. During World War II, the United Kingdom and the United States worked together to find a method of mass-producing penicillin, [5] a derivative of the Penicillium mold, which had the potential to save many lives during the war since it could treat infections common in injured soldiers. Although penicillin could be isolated from the mold in a laboratory setting, there was no known way to obtain the amount of medication needed to treat the quantity of people who needed it. Scientists with major chemical companies such as Pfizer were able to develop a deep-fermentation process which could produce a high yield of penicillin. In 1944, Pfizer opened the first penicillin factory, and its products were exported to aid the war efforts overseas. [6]

Controlled drug release

Tablets for oral consumption of medication have been utilized since approximately 1500 B.C.; [7] however, for a long time the only method of drug release was immediate release, meaning all of the medication is released in the body at once. [8] In the 1950s, sustained release technology was developed. Through mechanisms such as osmosis and diffusion, pills were designed that could release the medication over a 12-hour to 24-hour period. Smith, Kline & French developed one of the first major successful sustained release technologies. Their formulation consisted of a collection of small tablets taken at the same time, with varying amounts of wax coating that allowed some tablets to dissolve in the body faster than others. [9] The result was a continuous release of the drug as it travelled through the intestinal tract. Although modern day research focuses on extending the controlled release timescale to the order of months, once-a-day and twice-a-day pills are still the most widely utilized controlled drug release method. [8]

Formation of the ISPE

In 1980, the International Society for Pharmaceutical Engineering was formed to support and guide professionals in the pharmaceutical industry through all parts of the process of bringing new medications to the market. The ISPE writes standards and guidelines for individuals and companies to use and to model their practices after. The ISPE also hosts training sessions and conferences for professionals to attend, learn, and collaborate with others in the field. [10]

Pharmaceutical Design

A pharmaceutical engineer undertakes the pharmaceutical process involving design, material selection, and product manufacture. Engineers lead pharmaceutical companies in the field of development and improvement of production facilities. [11]

Quality Control is a prime element for pharmaceutical design engineering. [11]

Design Concept

The physical space and air flow control are main categories an engineer considers when evaluating laboratory design. The engineer focuses on establishing the activities undertaken in the laboratory through function and operation. Engineers determine the space requirement for each activity and laboratory undergoes. [11]

Applications and Practice

Pharmaceutical Engineers work with the principles of Heat Transfer. Applying heat transfer to the field of work explains the maximum metabolic load considered in design calculations as in gas-liquid oxygen transfer for an engineer. [12]

Operating conditions influence terminal mixing time and mean circulation time, this signifies the engineer contains the principles of mixing to undergo given projects in the pharmaceutical. [12]

Pharmaceutical engineering also uses the principles of bioprocess engineering to utilize resources necessary to promote the growth of microorganisms in a controlled environment for the purpose of projects like producing a product of biological origin. [12] [13]

Pharmaceutical engineers may also work with agitation, agitated bioreactors are designed by the engineer to maintain complete suspension for a homogeneous suspension. [12] [13]

Roller Compaction Technology

The pharmaceutical industry alongside pharmaceutical engineers use granulation methods to enlarge and densify small powder particles into larger ones. This improves powder flow so that the material can be processed effectively and efficiently further into solid dosage forms. The powder particles are aggregated under high pressure, typically 30 bar - 70 bar pressure. [14]

Pharmaceutical engineers incorporate the compaction theory for the bonding forces in a dry aggregate to granulation properties such as granule integrity, friability, and density. [14]

Pharmaceutical Engineering Facilities

Product and Processing

Toxicity and Potency

Physical Properties

Cleanability (Solubility)

Product and Material Flow

See also

References

  1. Reklaitis, G.V.; Khinast, J.; Muzzio, F. (November 2010). "Pharmaceutical engineering science—New approaches to pharmaceutical development and manufacturing". Chemical Engineering Science. 65 (21): iv–vii. doi:10.1016/j.ces.2010.08.041.
  2. "Top Pharmaceuticals: Introduction: EMERGENCE OF PHARMACEUTICAL SCIENCE AND INDUSTRY: 1870-1930". pubs.acs.org. Retrieved 2019-02-14.
  3. Williams, KJ (2009-08-01). "The introduction of 'chemotherapy' using arsphenamine – the first magic bullet". Journal of the Royal Society of Medicine. 102 (8): 343–348. doi:10.1258/jrsm.2009.09k036. ISSN   0141-0768. PMC   2726818 . PMID   19679737.
  4. "Chemical & Engineering News: Top Pharmaceuticals: Salvarsan". pubs.acs.org. Retrieved 2019-02-14.
  5. Quinn, Roswell (March 2013). "Rethinking Antibiotic Research and Development: World War II and the Penicillin Collaborative". American Journal of Public Health. 103 (3): 426–434. doi:10.2105/AJPH.2012.300693. ISSN   0090-0036. PMC   3673487 . PMID   22698031.
  6. "Penicillin Production through Deep-tank Fermentation - National Historic Chemical Landmark". American Chemical Society. Retrieved 2019-02-14.
  7. MESTEL, ROSIE (2002-03-25). "The Colorful History of Pills Can Fill Many a Tablet". Los Angeles Times. ISSN   0458-3035 . Retrieved 2019-03-19.
  8. 1 2 Yun, Yeon Hee; Lee, Byung Kook; Park, Kinam (2015-12-10). "Controlled Drug Delivery: Historical perspective for the next generation". Journal of Controlled Release. 219: 2–7. doi:10.1016/j.jconrel.2015.10.005. ISSN   0168-3659. PMC   4656096 . PMID   26456749.
  9. Oral controlled release formulation design and drug delivery : theory to practice. Hoboken, N.J.: Wiley. 2013. ISBN   9781118060322. OCLC   898985497.
  10. "About ISPE". ISPE | International Society for Pharmaceutical Engineering. Retrieved 2019-02-15.
  11. 1 2 3 Bennett, Bill (2003). Pharmaceutical Production: An Engineering Guide. Institution of Chemical Engineers (Great Britain) (published 1 January 2001). ISBN   9780852954409.
  12. 1 2 3 4 Hickey, Anthony J. (2001). Pharmaceutical Process Engineering (1st ed.). CRC Press (published 6 March 2001). ISBN   9780367394745.
  13. 1 2 Bladon, Christine M. (2002). Pharmaceutical Chemistry: Therapeutic Aspects of Biomacromolecules (1st ed.). Wiley (published 3 April 2002). ISBN   9780471496373.
  14. 1 2 Swarbrick, James (2022). Encyclopedia of Pharmaceutical Technology, Second Edition - Three Volume Set (Volume 2) (2nd ed.). CRC Press (published 23 May 2002). ISBN   9780824728250.
  15. 1 2 3 4 5 ISPE (2004). Pharmaceutical Engineering Guides for New and Renovated Facilities: Biopharmaceutical Manufacturing Facilities. ISPE Headquarters (published 4 July 2004). ISBN   9781931879095.